首页 > 最新文献

Journal of the American Medical Directors Association最新文献

英文 中文
Resource Factors Associated With Avoidable Transfers in Nursing Homes 与养老院可避免转移相关的资源因素。
IF 3.8 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2026-01-07 DOI: 10.1016/j.jamda.2025.106040
Matthew S. Farmer PhD, RN, Alisha H. Johnson PhD, RN, Kimberly R. Powell PhD, RN

Objectives

Reducing avoidable hospital transfers among nursing home (NH) residents remains a critical priority, with 20% to 67% of transfers potentially preventable. Despite evidence that embedded advanced practice registered nurses (APRNs) and enhanced resources reduce transfers, chronic underinvestment leaves NHs with inadequate staffing and limited diagnostic capabilities. This study examined which resource constraints contributed to avoidable transfers among NH residents with dementia.

Design

Cross-sectional analysis of transfer events collected during the Missouri Quality Initiative, a Centers for Medicare and Medicaid Services–funded intervention (2016–2020) that embedded APRNs, implemented INTERACT tools, and enhanced health information technology to reduce avoidable hospitalizations.

Setting and Participants

Sixteen Missouri NHs participated, encompassing 3683 hospital transfer events from long-term residents. APRNs completed INTERACT surveys documenting resource availability and transfer context.

Methods

Eleven resource indicators were extracted from APRN surveys. Exploratory factor analysis identified latent resource domains. Factor scores were analyzed using Bayesian generalized linear mixed models to assess associations with avoidable transfers, accounting for facility-level variation.

Results

Half (50.2%) of transfers were avoidable. Four resource domains emerged: Delayed Diagnostics, Lack of Expertise/Staffing, APRN and Registered Nurse (RN) Availability, and On-site Clinical Resources. Limited APRN availability and staff discomfort (factors 2 and 3) significantly increased the odds of avoidable transfers (OR ≈1.7), whereas the lack of on-site clinicians and equipment (factor 4) were associated with nonavoidable transfers (OR ≈0.37). In addition, facility-level differences contributed meaningfully to transfer decisions, suggesting that unmeasured organizational factors influence outcomes.

Conclusions and Implications

Avoidable transfers are driven by staff discomfort and limited APRN availability, revealing gaps in nursing jurisdiction and decision-making capacity. Practice and policy reforms should expand APRN access, strengthen diagnostic partnerships, leverage telehealth, and support closed provider models. These interventions are urgently needed to reduce costly, traumatic transfers and improve resident-centered care.
目标:减少疗养院(NH)居民可避免的医院转院仍然是一个关键的优先事项,20%至67%的转院可能是可以预防的。尽管有证据表明,嵌入式高级执业注册护士(APRNs)和资源的增加减少了转移,但长期投资不足导致NHs人员配备不足,诊断能力有限。本研究考察了哪些资源限制促成了NH居民与痴呆症之间可避免的转移。设计:对密苏里质量倡议期间收集的转移事件进行横断面分析,密苏里质量倡议是一项由医疗保险和医疗补助服务中心资助的干预(2016-2020年),该干预嵌入了APRNs,实施了INTERACT工具,并增强了卫生信息技术,以减少可避免的住院治疗。环境和参与者:参与了16个密苏里州的NHs,包括3683个长期居民的医院转院事件。aprn完成了记录资源可用性和转移背景的INTERACT调查。方法:从APRN调查中提取11个资源指标。探索性因子分析确定了潜在资源域。使用贝叶斯广义线性混合模型分析因子得分,以评估与可避免转移的关联,考虑到设施水平的变化。结果:半数(50.2%)的转移是可以避免的。出现了四个资源领域:延迟诊断,缺乏专业知识/人员配置,APRN和注册护士(RN)可用性,以及现场临床资源。有限的APRN可用性和员工不适(因素2和3)显著增加了可避免转移的几率(OR≈1.7),而缺乏现场临床医生和设备(因素4)与不可避免转移相关(OR≈0.37)。此外,设施水平差异对迁移决策有意义的贡献,表明未测量的组织因素影响结果。结论和意义:可避免的转院是由员工不适和有限的APRN可用性驱动的,揭示了护理管辖权和决策能力的差距。实践和政策改革应扩大APRN的可及性,加强诊断伙伴关系,利用远程医疗,并支持封闭提供者模式。这些干预措施是迫切需要的,以减少昂贵的创伤转移和改善以居民为中心的护理。
{"title":"Resource Factors Associated With Avoidable Transfers in Nursing Homes","authors":"Matthew S. Farmer PhD, RN,&nbsp;Alisha H. Johnson PhD, RN,&nbsp;Kimberly R. Powell PhD, RN","doi":"10.1016/j.jamda.2025.106040","DOIUrl":"10.1016/j.jamda.2025.106040","url":null,"abstract":"<div><h3>Objectives</h3><div>Reducing avoidable hospital transfers among nursing home (NH) residents remains a critical priority, with 20% to 67% of transfers potentially preventable. Despite evidence that embedded advanced practice registered nurses (APRNs) and enhanced resources reduce transfers, chronic underinvestment leaves NHs with inadequate staffing and limited diagnostic capabilities. This study examined which resource constraints contributed to avoidable transfers among NH residents with dementia.</div></div><div><h3>Design</h3><div>Cross-sectional analysis of transfer events collected during the Missouri Quality Initiative, a Centers for Medicare and Medicaid Services–funded intervention (2016–2020) that embedded APRNs, implemented INTERACT tools, and enhanced health information technology to reduce avoidable hospitalizations.</div></div><div><h3>Setting and Participants</h3><div>Sixteen Missouri NHs participated, encompassing 3683 hospital transfer events from long-term residents. APRNs completed INTERACT surveys documenting resource availability and transfer context.</div></div><div><h3>Methods</h3><div>Eleven resource indicators were extracted from APRN surveys. Exploratory factor analysis identified latent resource domains. Factor scores were analyzed using Bayesian generalized linear mixed models to assess associations with avoidable transfers, accounting for facility-level variation.</div></div><div><h3>Results</h3><div>Half (50.2%) of transfers were avoidable. Four resource domains emerged: Delayed Diagnostics, Lack of Expertise/Staffing, APRN and Registered Nurse (RN) Availability, and On-site Clinical Resources. Limited APRN availability and staff discomfort (factors 2 and 3) significantly increased the odds of avoidable transfers (OR ≈1.7), whereas the lack of on-site clinicians and equipment (factor 4) were associated with nonavoidable transfers (OR ≈0.37). In addition, facility-level differences contributed meaningfully to transfer decisions, suggesting that unmeasured organizational factors influence outcomes.</div></div><div><h3>Conclusions and Implications</h3><div>Avoidable transfers are driven by staff discomfort and limited APRN availability, revealing gaps in nursing jurisdiction and decision-making capacity. Practice and policy reforms should expand APRN access, strengthen diagnostic partnerships, leverage telehealth, and support closed provider models. These interventions are urgently needed to reduce costly, traumatic transfers and improve resident-centered care.</div></div>","PeriodicalId":17180,"journal":{"name":"Journal of the American Medical Directors Association","volume":"27 2","pages":"Article 106040"},"PeriodicalIF":3.8,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145810488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 Vaccination and Impact on Morbidity Among Nursing Home Residents, October 2024–January 2025: An Ecological Analysis 2024年10月- 2025年1月疗养院居民COVID-19疫苗接种及其对发病率的影响:生态学分析
IF 3.8 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2026-01-06 DOI: 10.1016/j.jamda.2025.106029
Farid L. Khan MPH, Jenny Boucher PharmD, Timothy L. Wiemken PhD, Angela D. Cook MS, Tobias Bergroth PhD, Alon Yehoshua PharmD, Evan J. Zasowski PharmD, Santiago M.C. Lopez MD, Laura A. Puzniak PhD

Objectives

US nursing home residents experience a disproportionate burden of COVID-19–associated cases and hospitalizations. COVID-19 vaccination may reduce the burden in this population; however, data on the association between vaccine uptake and outcomes for this vulnerable population are lacking.

Design

Retrospective, observational ecological study.

Setting and Participants

Facility-level nursing home resident information from the Centers for Disease Control and Prevention's National Healthcare Safety Network Long-Term Care Facility COVID-19 Module database from October 5, 2024, to January 5, 2025.

Methods

Facility-level COVID-19 vaccination uptake and COVID-19 outcomes were linked with sociodemographic, economic, and facility characteristics. Generalized estimating equations were used to assess associations between vaccination uptake and COVID-19 cases and hospitalizations, controlling for potential confounders.

Results

The study included up to 13 weeks of data from 12,665 facilities (168,278 facility-weeks total). COVID-19 vaccination uptake increased from 14.8% to 40.0% over the study period. A 10% increase in vaccination uptake was associated with a significant reduction in COVID-19 cases [adjusted incidence rate ratio (ARR), 0.94; 95% CI, 0.91–0.97] and hospitalizations (ARR, 0.91; 95% CI, 0.86–0.95) among up-to-date residents. Facilities with higher vaccination rates experienced fewer weekly COVID-19 cases and hospitalizations.

Conclusions and Implications

Increased COVID-19 vaccination rates among nursing home residents are associated with reduced cases and hospitalizations, underscoring the importance of vaccination as a public health strategy in this vulnerable population. Efforts to improve COVID-19 vaccine uptake are warranted and could include revision of quality measures ratings to align COVID-19 vaccination with flu vaccination requirements.
目标:美国养老院的居民承受着与covid -19相关的病例和住院治疗的不成比例的负担。COVID-19疫苗接种可减轻这一人群的负担;然而,缺乏关于这一脆弱人群接种疫苗与结果之间关系的数据。设计:回顾性观察生态学研究。环境和参与者:2024年10月5日至2025年1月5日,来自疾病预防控制中心国家医疗安全网络长期护理设施COVID-19模块数据库的设施级养老院居民信息。方法:设施级COVID-19疫苗接种率和COVID-19结局与社会人口统计学、经济和设施特征相关。使用广义估计方程来评估疫苗接种与COVID-19病例和住院之间的关系,控制潜在的混杂因素。结果:该研究包括来自12,665个设施(共168,278个设施周)长达13周的数据。在研究期间,COVID-19疫苗接种率从14.8%增加到40.0%。在最新居民中,疫苗接种率增加10%与COVID-19病例(调整发病率比[ARR], 0.94; 95% CI, 0.91-0.97)和住院率(ARR, 0.91; 95% CI, 0.86-0.95)的显著减少相关。疫苗接种率较高的设施每周的COVID-19病例和住院人数较少。结论和意义:养老院居民中COVID-19疫苗接种率的提高与病例和住院率的减少有关,强调了疫苗接种作为这一弱势群体公共卫生战略的重要性。有必要努力提高COVID-19疫苗的吸收率,包括修订质量措施评级,使COVID-19疫苗接种符合流感疫苗接种要求。
{"title":"COVID-19 Vaccination and Impact on Morbidity Among Nursing Home Residents, October 2024–January 2025: An Ecological Analysis","authors":"Farid L. Khan MPH,&nbsp;Jenny Boucher PharmD,&nbsp;Timothy L. Wiemken PhD,&nbsp;Angela D. Cook MS,&nbsp;Tobias Bergroth PhD,&nbsp;Alon Yehoshua PharmD,&nbsp;Evan J. Zasowski PharmD,&nbsp;Santiago M.C. Lopez MD,&nbsp;Laura A. Puzniak PhD","doi":"10.1016/j.jamda.2025.106029","DOIUrl":"10.1016/j.jamda.2025.106029","url":null,"abstract":"<div><h3>Objectives</h3><div>US nursing home residents experience a disproportionate burden of COVID-19–associated cases and hospitalizations. COVID-19 vaccination may reduce the burden in this population; however, data on the association between vaccine uptake and outcomes for this vulnerable population are lacking.</div></div><div><h3>Design</h3><div>Retrospective, observational ecological study.</div></div><div><h3>Setting and Participants</h3><div>Facility-level nursing home resident information from the Centers for Disease Control and Prevention's National Healthcare Safety Network Long-Term Care Facility COVID-19 Module database from October 5, 2024, to January 5, 2025.</div></div><div><h3>Methods</h3><div>Facility-level COVID-19 vaccination uptake and COVID-19 outcomes were linked with sociodemographic, economic, and facility characteristics. Generalized estimating equations were used to assess associations between vaccination uptake and COVID-19 cases and hospitalizations, controlling for potential confounders.</div></div><div><h3>Results</h3><div>The study included up to 13 weeks of data from 12,665 facilities (168,278 facility-weeks total). COVID-19 vaccination uptake increased from 14.8% to 40.0% over the study period. A 10% increase in vaccination uptake was associated with a significant reduction in COVID-19 cases [adjusted incidence rate ratio (ARR), 0.94; 95% CI, 0.91–0.97] and hospitalizations (ARR, 0.91; 95% CI, 0.86–0.95) among up-to-date residents. Facilities with higher vaccination rates experienced fewer weekly COVID-19 cases and hospitalizations.</div></div><div><h3>Conclusions and Implications</h3><div>Increased COVID-19 vaccination rates among nursing home residents are associated with reduced cases and hospitalizations, underscoring the importance of vaccination as a public health strategy in this vulnerable population. Efforts to improve COVID-19 vaccine uptake are warranted and could include revision of quality measures ratings to align COVID-19 vaccination with flu vaccination requirements.</div></div>","PeriodicalId":17180,"journal":{"name":"Journal of the American Medical Directors Association","volume":"27 3","pages":"Article 106029"},"PeriodicalIF":3.8,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145751770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prescription Patterns and Associated Factors of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors Use Among Patients Worldwide: A Systematic Review and Meta-Analysis of Real-World Studies 处方模式和全球患者使用SGLT2抑制剂的相关因素:对真实世界研究的系统回顾和荟萃分析
IF 3.8 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2026-01-06 DOI: 10.1016/j.jamda.2025.106036
Man Xu MSc, Quanzhi Li MSc, Ning Chen MSc, Xi Zhang PhD, Wei Zhang PhD

Objectives

The prescribing patterns of sodium-glucose cotransporter 2 (SGLT2) inhibitors in real-world clinical practice remain inadequately characterized. To address this gap, this meta-analysis aims to synthesize evidence on the prescription trends and clinical factors associated with SGLT2 inhibitor use.

Design

Systematic review and meta-analysis.

Setting and Participants

Patients with type 2 diabetes, chronic kidney disease, or cardiovascular disease.

Methods

Studies that were conducted to assess SGLT2 inhibitor use among patients were screened. From its inception until November 4, 2024, searches were conducted in PubMed, Web of Science, and Embase. Statistical analyses were performed with Review Manager (RevMan) version 5.4 and Stata 18.0.

Results

The study examined data from 102 studies, revealing a compelling global prevalence of SGLT2 inhibitors of 12% (95% CI, 11%-13%). The pooled prevalence of SGLT2 inhibitor use was 13% (95% CI, 11%-14%) in patients with cardiovascular disease, followed by type 2 diabetes at 12% (95% CI, 11%-13%) and chronic kidney disease at 11% (95% CI, 9%-13%). The use of SGLT2 inhibitors was significantly higher in patients who were enrolled after December 2020 compared with those enrolled before that date (20% vs 9%). The prescribing of SGLT2 inhibitors is significantly related to age, sex, body mass index, Medicare, and endocrinology visits.

Conclusions and Implications

The meta-analysis indicates that the real-world use of SGLT2 inhibitors increased gradually up to 2020. The synthesized evidence revealed variations in usage across different patient subgroups, which require addressing the identified barriers in the future to ensure optimal prescribing.
目的:钠-葡萄糖共转运蛋白2 (SGLT2)抑制剂的处方模式在现实世界的临床实践中仍然没有充分表征。为了解决这一差距,本荟萃分析旨在综合与SGLT2抑制剂使用相关的处方趋势和临床因素的证据。设计:系统回顾和荟萃分析。环境和参与者:患有2型糖尿病、慢性肾病或心血管疾病的患者。方法:筛选用于评估患者使用SGLT2抑制剂的研究。从其成立到2024年11月4日,在PubMed、Web of Science和Embase中进行了搜索。使用Review Manager (RevMan) 5.4版和Stata 18.0进行统计分析。结果:该研究检查了102项研究的数据,显示SGLT2抑制剂的全球患病率为12% (95% CI, 11%-13%)。心血管疾病患者使用SGLT2抑制剂的总患病率为13% (95% CI, 11%-14%),其次是2型糖尿病患者为12% (95% CI, 11%-13%)和慢性肾病患者为11% (95% CI, 9%-13%)。在2020年12月之后入组的患者中,SGLT2抑制剂的使用明显高于在该日期之前入组的患者(20% vs 9%)。SGLT2抑制剂的处方与年龄、性别、体重指数、医疗保险和内分泌学就诊显著相关。结论和意义:荟萃分析表明,到2020年,SGLT2抑制剂的实际使用逐渐增加。综合证据揭示了不同患者亚组的使用差异,这需要解决未来确定的障碍,以确保最佳处方。
{"title":"Prescription Patterns and Associated Factors of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors Use Among Patients Worldwide: A Systematic Review and Meta-Analysis of Real-World Studies","authors":"Man Xu MSc,&nbsp;Quanzhi Li MSc,&nbsp;Ning Chen MSc,&nbsp;Xi Zhang PhD,&nbsp;Wei Zhang PhD","doi":"10.1016/j.jamda.2025.106036","DOIUrl":"10.1016/j.jamda.2025.106036","url":null,"abstract":"<div><h3>Objectives</h3><div>The prescribing patterns of sodium-glucose cotransporter 2 (SGLT2) inhibitors in real-world clinical practice remain inadequately characterized. To address this gap, this meta-analysis aims to synthesize evidence on the prescription trends and clinical factors associated with SGLT2 inhibitor use.</div></div><div><h3>Design</h3><div>Systematic review and meta-analysis.</div></div><div><h3>Setting and Participants</h3><div>Patients with type 2 diabetes, chronic kidney disease, or cardiovascular disease.</div></div><div><h3>Methods</h3><div>Studies that were conducted to assess SGLT2 inhibitor use among patients were screened. From its inception until November 4, 2024, searches were conducted in PubMed, Web of Science, and Embase. Statistical analyses were performed with Review Manager (RevMan) version 5.4 and Stata 18.0.</div></div><div><h3>Results</h3><div>The study examined data from 102 studies, revealing a compelling global prevalence of SGLT2 inhibitors of 12% (95% CI, 11%-13%). The pooled prevalence of SGLT2 inhibitor use was 13% (95% CI, 11%-14%) in patients with cardiovascular disease, followed by type 2 diabetes at 12% (95% CI, 11%-13%) and chronic kidney disease at 11% (95% CI, 9%-13%). The use of SGLT2 inhibitors was significantly higher in patients who were enrolled after December 2020 compared with those enrolled before that date (20% vs 9%). The prescribing of SGLT2 inhibitors is significantly related to age, sex, body mass index, Medicare, and endocrinology visits.</div></div><div><h3>Conclusions and Implications</h3><div>The meta-analysis indicates that the real-world use of SGLT2 inhibitors increased gradually up to 2020. The synthesized evidence revealed variations in usage across different patient subgroups, which require addressing the identified barriers in the future to ensure optimal prescribing.</div></div>","PeriodicalId":17180,"journal":{"name":"Journal of the American Medical Directors Association","volume":"27 2","pages":"Article 106036"},"PeriodicalIF":3.8,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145810476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healing at Home: Receipt of Home Health Care and Patient-Centered Outcomes Among Older Adults After Acute Myocardial Infarction. 在家治疗:接受家庭保健和老年人急性心肌梗死后以病人为中心的结果
IF 3.8 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2026-01-03 DOI: 10.1016/j.jamda.2025.106063
Alexandra M Hajduk, Jason R Falvey, Jingjing Shang, Lisa M Kern, Madeline Sterling, Sui Tsang, Jeph Herrin, Sarwat I Chaudhry

Objective: To evaluate the impact of receipt of home health care (HHC) on the patient-centered outcomes of days not at home (DNAH) and risk of decline in physical and mental health status among older adults hospitalized with acute myocardial infarction (AMI).

Design: Secondary analysis of data from a national prospective cohort study.

Setting and participants: Adults age ≥75 years discharged home after an AMI hospitalization and linked to Medicare data.

Methods: The primary exposure was receipt of HHC by 14 days postdischarge. DNAH within 180 days after discharge was defined as the count of days spent deceased or in a hospital, skilled nursing facility, or inpatient rehab facility. Health status decline was defined as a decrease ≥5 points on the SF-12 from baseline to 180 days. Inverse probability of treatment-weighted generalized linear models was used to evaluate associations between receipt of HHC and these outcomes.

Results: A total of 491 of 1846 (26.6%) participants received HHC within 14 days; HHC recipients were older and had greater clinical and functional comorbidity. HHC was not associated with DNAH (incidence rate ratio [IRR], 1.24; 95% CI, 0.99-1.56) nor risk of decline in mental health status (odds ratio [OR], 0.83; 95% CI, 0.64-1.07), but was associated with substantially reduced risk of decline in physical health status (OR, 0.70; 95% CI, 0.56-0.89).

Conclusions and implications: More than one-quarter of patients with AMI age ≥75 discharged home received HHC. Patients who received HHC, who were older and sicker on average, were less likely to experience clinically significant declines in physical health status but had similar rates of mental health status decline and DNAH as those who did not receive HHC. This work suggests that providers consider the health outcome goals of older AMI patients and prescribe HHC to those who prioritize preservation of physical health status.

目的:评价接受家庭卫生保健(HHC)对急性心肌梗死(AMI)住院老年人不在家天数(DNAH)和身心健康状况下降风险的影响。设计:对国家前瞻性队列研究数据进行二次分析。环境和参与者:年龄≥75岁的成年人在AMI住院后出院,并与医疗保险数据相关。方法:首次接触者为出院后14天接受HHC。出院后180天内的DNAH被定义为死亡或在医院、专业护理机构或住院康复机构度过的天数。健康状况下降被定义为从基线到180天SF-12下降≥5分。使用治疗加权广义线性模型的逆概率来评估接受HHC与这些结果之间的关系。结果:1846名参与者中,共有491名(26.6%)在14天内接受了HHC治疗;HHC受者年龄较大,有较大的临床和功能合并症。HHC与DNAH(发病率比[IRR], 1.24; 95% CI, 0.99-1.56)和精神健康状况下降的风险无关(比值比[OR], 0.83; 95% CI, 0.64-1.07),但与身体健康状况下降的风险显著降低相关(OR, 0.70; 95% CI, 0.56-0.89)。结论和意义:超过四分之一年龄≥75岁的AMI患者出院后接受了HHC治疗。接受HHC治疗的患者年龄较大,平均病情较重,身体健康状况出现临床显著下降的可能性较小,但与未接受HHC治疗的患者相比,精神健康状况下降和DNAH的发生率相似。这项工作表明,提供者考虑老年AMI患者的健康结果目标,并为那些优先考虑保持身体健康状态的患者开HHC。
{"title":"Healing at Home: Receipt of Home Health Care and Patient-Centered Outcomes Among Older Adults After Acute Myocardial Infarction.","authors":"Alexandra M Hajduk, Jason R Falvey, Jingjing Shang, Lisa M Kern, Madeline Sterling, Sui Tsang, Jeph Herrin, Sarwat I Chaudhry","doi":"10.1016/j.jamda.2025.106063","DOIUrl":"https://doi.org/10.1016/j.jamda.2025.106063","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the impact of receipt of home health care (HHC) on the patient-centered outcomes of days not at home (DNAH) and risk of decline in physical and mental health status among older adults hospitalized with acute myocardial infarction (AMI).</p><p><strong>Design: </strong>Secondary analysis of data from a national prospective cohort study.</p><p><strong>Setting and participants: </strong>Adults age ≥75 years discharged home after an AMI hospitalization and linked to Medicare data.</p><p><strong>Methods: </strong>The primary exposure was receipt of HHC by 14 days postdischarge. DNAH within 180 days after discharge was defined as the count of days spent deceased or in a hospital, skilled nursing facility, or inpatient rehab facility. Health status decline was defined as a decrease ≥5 points on the SF-12 from baseline to 180 days. Inverse probability of treatment-weighted generalized linear models was used to evaluate associations between receipt of HHC and these outcomes.</p><p><strong>Results: </strong>A total of 491 of 1846 (26.6%) participants received HHC within 14 days; HHC recipients were older and had greater clinical and functional comorbidity. HHC was not associated with DNAH (incidence rate ratio [IRR], 1.24; 95% CI, 0.99-1.56) nor risk of decline in mental health status (odds ratio [OR], 0.83; 95% CI, 0.64-1.07), but was associated with substantially reduced risk of decline in physical health status (OR, 0.70; 95% CI, 0.56-0.89).</p><p><strong>Conclusions and implications: </strong>More than one-quarter of patients with AMI age ≥75 discharged home received HHC. Patients who received HHC, who were older and sicker on average, were less likely to experience clinically significant declines in physical health status but had similar rates of mental health status decline and DNAH as those who did not receive HHC. This work suggests that providers consider the health outcome goals of older AMI patients and prescribe HHC to those who prioritize preservation of physical health status.</p>","PeriodicalId":17180,"journal":{"name":"Journal of the American Medical Directors Association","volume":" ","pages":"106063"},"PeriodicalIF":3.8,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Directions & Connections 方向和连接
IF 3.8 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2026-01-01 DOI: 10.1016/S1525-8610(25)00616-4
{"title":"Directions & Connections","authors":"","doi":"10.1016/S1525-8610(25)00616-4","DOIUrl":"10.1016/S1525-8610(25)00616-4","url":null,"abstract":"","PeriodicalId":17180,"journal":{"name":"Journal of the American Medical Directors Association","volume":"27 1","pages":"Article 106099"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145976486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient- Versus Provider-Centered Care 以病人为中心与以提供者为中心的护理
IF 3.8 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.jamda.2025.106009
Barbara Resnick PhD, CRNP , Paul Katz MD
{"title":"Patient- Versus Provider-Centered Care","authors":"Barbara Resnick PhD, CRNP ,&nbsp;Paul Katz MD","doi":"10.1016/j.jamda.2025.106009","DOIUrl":"10.1016/j.jamda.2025.106009","url":null,"abstract":"","PeriodicalId":17180,"journal":{"name":"Journal of the American Medical Directors Association","volume":"27 1","pages":"Article 106009"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145976489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Nonpharmacological Approach to Skin Picking in a Patient With Alzheimer's Dementia: A Case Report 一种非药物方法的皮肤采摘患者阿尔茨海默氏痴呆症:一个病例报告。
IF 3.8 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.jamda.2025.105951
Ujunwa Ebili MD, Esther S. Oh MD, PhD, Mfon E. Umoh MD, PhD
{"title":"A Nonpharmacological Approach to Skin Picking in a Patient With Alzheimer's Dementia: A Case Report","authors":"Ujunwa Ebili MD,&nbsp;Esther S. Oh MD, PhD,&nbsp;Mfon E. Umoh MD, PhD","doi":"10.1016/j.jamda.2025.105951","DOIUrl":"10.1016/j.jamda.2025.105951","url":null,"abstract":"","PeriodicalId":17180,"journal":{"name":"Journal of the American Medical Directors Association","volume":"27 1","pages":"Article 105951"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145345978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine Learning in Sarcopenia Diagnosis: Promising but Requires Caution in Clinical Translation 机器学习在肌少症诊断中的应用:在临床翻译中有希望但需要谨慎。
IF 3.8 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.jamda.2025.105958
Huan Luo MSc, Lei Pu PhD
{"title":"Machine Learning in Sarcopenia Diagnosis: Promising but Requires Caution in Clinical Translation","authors":"Huan Luo MSc,&nbsp;Lei Pu PhD","doi":"10.1016/j.jamda.2025.105958","DOIUrl":"10.1016/j.jamda.2025.105958","url":null,"abstract":"","PeriodicalId":17180,"journal":{"name":"Journal of the American Medical Directors Association","volume":"27 1","pages":"Article 105958"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145422065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in Patient Medical Complexity After Skilled Nursing Facility Payment Reform: A Qualitative Study 熟练护理机构支付改革后患者医疗复杂性的变化:一项定性研究。
IF 3.8 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.jamda.2025.106019
Natalie E. Leland PhD, OTR/L , Rachel A. Prusynski DPT, PhD , Amanda Shore COTA/L , Harsha Amaravadi MPH , Tracy Mroz PhD, OTR/L , Debra Saliba MD, MPH

Objectives

The skilled nursing facility (SNF) patient-driven payment model (PDPM) is intended to align payment with patient clinical characteristics to more accurately compensate complex and resource intensive care. However, it is unclear whether and how SNFs shifted their admission practices to align PDPM's financial incentives. This study examined SNF leaders’ perspectives on changes in admission practices and patient case mix in order to understand variation in responses to PDPM implementation.

Design

A qualitative study.

Setting and Participants

A purposive sample of SNF leaders from across the United States [eg, average to high (3–5 stars) and below-average (1–2 stars) care quality].

Methods

Ninety-four SNF leaders participated in one-on-one semistructured interviews between January 2021 and December 2022. Thematic analysis examined leaders’ perspectives of their organization’s response to PDPM, including changes in admission practices and patient case mix, as well as contextual factors contributing to their response. We then examined patterns by SNF quality rating and admission practice changes.

Results

Descriptions of whether and why SNF case mix change differed based on their history of caring for a medically complex patient population. Leaders of SNFs that historically cared for rehabilitation patients frequently described strategic changes in their admission practices (eg, enhanced preadmission screening) after PDPM to prioritize the admission of medically complex patients, including those with higher nursing-related care needs (eg, tracheostomy, wounds, peritoneal dialysis). These leaders tended to represent average or high-quality SNFs, whereas leaders from below-average quality SNFs more frequently reported minimal or no case mix changes, in part reflecting a history of admitting medically complex patients before PDPM.

Conclusions and Implications

Results suggest that PDPM’s intended effect of shifting SNF admissions to more medically complex patients varied by baseline SNF admission patterns and characteristics. These findings can inform longitudinal national evaluations of organizational responses to PDPM implementation.
目的:熟练护理设施(SNF)患者驱动的支付模式(PDPM)旨在使支付与患者临床特征保持一致,以更准确地补偿复杂和资源密集型护理。然而,目前尚不清楚snf是否以及如何改变他们的录取做法,以配合PDPM的财政激励。本研究考察了SNF领导人对入院实践和患者病例组合变化的看法,以了解对PDPM实施的反应的变化。设计:定性研究。背景和参与者:对来自美国各地的SNF领导者(例如,平均到高[3-5星]和低于平均[1-2星]的护理质量)进行有目的的抽样。方法:在2021年1月至2022年12月期间,94名SNF领导人参加了一对一的半结构化访谈。专题分析考察了领导者对其组织应对PDPM的看法,包括入院做法和患者病例组合的变化,以及影响其应对的背景因素。然后,我们通过SNF质量评级和录取实践变化来检查模式。结果:对SNF病例组合变化是否及原因的描述基于他们对医学复杂患者群体的护理史而有所不同。历来照顾康复患者的snf领导人经常描述他们在PDPM后入院实践的战略变化(例如,加强入院前筛查),以优先收治医疗复杂的患者,包括那些具有较高护理相关护理需求的患者(例如,气管切开术、伤口、腹膜透析)。这些领导者往往代表平均或高质量的snf,而低于平均质量的snf的领导者更频繁地报告病例组合变化很小或没有变化,部分反映了在PDPM之前接收医学复杂患者的历史。结论和意义:结果表明,PDPM将SNF入院转移到更复杂的患者的预期效果因基线SNF入院模式和特征而异。这些发现可以为组织对实施PDPM的反应进行纵向国家评价提供信息。
{"title":"Changes in Patient Medical Complexity After Skilled Nursing Facility Payment Reform: A Qualitative Study","authors":"Natalie E. Leland PhD, OTR/L ,&nbsp;Rachel A. Prusynski DPT, PhD ,&nbsp;Amanda Shore COTA/L ,&nbsp;Harsha Amaravadi MPH ,&nbsp;Tracy Mroz PhD, OTR/L ,&nbsp;Debra Saliba MD, MPH","doi":"10.1016/j.jamda.2025.106019","DOIUrl":"10.1016/j.jamda.2025.106019","url":null,"abstract":"<div><h3>Objectives</h3><div>The skilled nursing facility (SNF) patient-driven payment model (PDPM) is intended to align payment with patient clinical characteristics to more accurately compensate complex and resource intensive care. However, it is unclear whether and how SNFs shifted their admission practices to align PDPM's financial incentives. This study examined SNF leaders’ perspectives on changes in admission practices and patient case mix in order to understand variation in responses to PDPM implementation.</div></div><div><h3>Design</h3><div>A qualitative study.</div></div><div><h3>Setting and Participants</h3><div>A purposive sample of SNF leaders from across the United States [eg, average to high (3–5 stars) and below-average (1–2 stars) care quality].</div></div><div><h3>Methods</h3><div>Ninety-four SNF leaders participated in one-on-one semistructured interviews between January 2021 and December 2022. Thematic analysis examined leaders’ perspectives of their organization’s response to PDPM, including changes in admission practices and patient case mix, as well as contextual factors contributing to their response. We then examined patterns by SNF quality rating and admission practice changes.</div></div><div><h3>Results</h3><div>Descriptions of whether and why SNF case mix change differed based on their history of caring for a medically complex patient population. Leaders of SNFs that historically cared for rehabilitation patients frequently described strategic changes in their admission practices (eg, enhanced preadmission screening) after PDPM to prioritize the admission of medically complex patients, including those with higher nursing-related care needs (eg, tracheostomy, wounds, peritoneal dialysis). These leaders tended to represent average or high-quality SNFs, whereas leaders from below-average quality SNFs more frequently reported minimal or no case mix changes, in part reflecting a history of admitting medically complex patients before PDPM.</div></div><div><h3>Conclusions and Implications</h3><div>Results suggest that PDPM’s intended effect of shifting SNF admissions to more medically complex patients varied by baseline SNF admission patterns and characteristics. These findings can inform longitudinal national evaluations of organizational responses to PDPM implementation.</div></div>","PeriodicalId":17180,"journal":{"name":"Journal of the American Medical Directors Association","volume":"27 1","pages":"Article 106019"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145654746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PALTmed Events and Product palm事件和产品
IF 3.8 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2026-01-01 DOI: 10.1016/S1525-8610(25)00617-6
{"title":"PALTmed Events and Product","authors":"","doi":"10.1016/S1525-8610(25)00617-6","DOIUrl":"10.1016/S1525-8610(25)00617-6","url":null,"abstract":"","PeriodicalId":17180,"journal":{"name":"Journal of the American Medical Directors Association","volume":"27 1","pages":"Article 106100"},"PeriodicalIF":3.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145976488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the American Medical Directors Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1